期刊文献+

糖尿病肾病患者蛋白氧化损伤的研究 被引量:1

Study on oxidative protein damage in diabetic nephropathy
下载PDF
导出
摘要 目的检测糖尿病肾病不同阶段患者血清晚期氧化蛋白产物水平及蛋白羰基含量,评价蛋白氧化损伤程度。方法根据24小时尿白蛋白定量将糖尿病患者分为单纯糖尿病组(DM组)、糖尿病早期肾病组(DN1组)、糖尿病肾病组(DN2组),并设健康对照组(NC组),检测各组血清晚期氧化蛋白产物(advanced oxidation prote inproducts,AOPPs)、蛋白质羰基含量(prote in carbonyl,PCO)水平。结果DM组血AOPPs、PCO较NC组明显升高,DN组患者血AOPPs、PCO较DM组明显升高,且随着肾病的进展AOPPs、PCO逐渐升高,组间差异均具有统计学意义(P<0.05)。结论糖尿病肾病患者蛋白氧化损伤较单纯糖尿病患者明显加重,而且随着糖尿病肾病的进展,蛋白氧化损伤进一步加重,蛋白氧化损伤产物积累增多。 Objective : To study oxidative protein damage in diabetic nephropathy patients through determination of serum AOPPs and PCO levels. Methods: Diabetic patients were divided into three groups according to 24h urinary albumin determination, serum AOPPs and PCO levels of these patients and normal controls were measured. Results: Serum AOPPs and PCO levels were significantly higher in diabetic patients( DM ,DN1 ,DN2) than those in the controls, and the levels became significantly higher as nephropathy developed( P 〈 0.05 ). Conclusion: Oxidative protein damage increases in diabetic patients, and becomes more serious when complicated with nephropathy, and more products of oxidative protein damage are accumulated simultaneously.
出处 《泰山医学院学报》 CAS 2009年第6期407-409,共3页 Journal of Taishan Medical College
关键词 糖尿病肾病 蛋白氧化损伤 晚期氧化蛋白产物 蛋白羰基 diabetic nephropathy oxidative protein damage advanced oxidation protein products protein carbonyl
  • 相关文献

参考文献8

  • 1Piwowar A,Knapik-Kordecka M,Warwas M.AOPP and its relations with selected markers of oxidative/antioxidative system in type 2 diabetes mellitus[J].Diabetes Res Clin Pract,2007,77 (2):188-192.
  • 2DaRe-Donne I,Rossi R,Giustarini D,et al.Protein carbonyl groups as biomarkers of oxidative stress[J].Clin Chim Acta,2003,329(1-2):23-38.
  • 3袁方,刘尚喜,侯凡凡,陈瑗,田建伟,刘志强.晚期氧化蛋白产物导致血管内皮细胞氧化应激损伤[J].解放军医学杂志,2004,29(11):951-954. 被引量:20
  • 4张志辉,刘尚喜,侯凡凡,田建伟,王力,刘志强,陈瑗.晚期氧化蛋白产物通过活性氧诱导单核细胞分泌肿瘤坏死因子[J].第一军医大学学报,2005,25(5):493-497. 被引量:17
  • 5Li HY,Hou FF,Zhang X,et al.Advanced oxidation pmtein products accelerate renal fibrosis in a remnant kidney model[J].J Am Soc Nephrol,2007,18(2):528-538.
  • 6Telci A,Cakatay U,Kayali R,et al.Oxidative protein damage in plasma of type 2 diabetic patients[J].Horm Metab Res,2000,32 (1):40-43.
  • 7Telci A,Cakatay U,Salman S,et al.Oxidative protein damage in early stage Type 1 diabetic patients[J].Diabetes Res Clin Pract,2000,50(3):213-223.
  • 8Martin-Gallan P,Carrascosa A,Gussinye M,et al.Biomarkers of diabetes-associated oxidative stress and antioxidant status in young diabetic patients with or without subclinical complications[J].Free Radic Biol Med,2003,34(12):1563-1574.

二级参考文献32

  • 1梁敏,王力,侯凡凡,刘俊,刘志强,田建伟.单核细胞活化与终末期肾病炎症反应状态的关系[J].第一军医大学学报,2003,23(8):781-784. 被引量:4
  • 2[1]Witko-Sarsat V, Friedlander M, Capeillere-Blandin C et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int, 1996, 49(5):1304
  • 3[2]Witko-Sarsat V, Friedlander M, Nguyen AT et al. Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol,1998, 161(5):2524
  • 4[3]Witko-Sarsat V, Gausson V, Nguyen AT et al. AOPP-induced activation of human neutrophil and monocyte oxidative metabolism: a potential target for N-acetylcysteine treatment in dialysis patients. Kidney Int, 2003, 64(1):82
  • 5[4]Kaneda H, Taguchi J, Ogasawara K et al. Increased level of advanced oxidation protein products in patients with coronary artery disease. Atherosclerosis, 2002, 162(1):221
  • 6[5]Drueke T, Witko-Sarsat V, Massy Z et al. Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease. Circulation, 2002, 106(17):2212
  • 7[7]Hansen MB, Nielsen SE, Berg K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods, 1989, 119(2):203
  • 8[8]Carter WO, Narayanan PK, Robinson JP. Intracellular hydrogen peroxide and superoxide anion detection in endothelial cells. J Leukoc Biol, 1994, 55(2):253
  • 9[9]SX, Chen Y, Zhou M et al. Inhibitory effect of ebselen on the oxidation of low density lipoprotein. Redox Report, 1995,1:357
  • 10[10]Jungers P, Massy ZA, Khoa TN et al. Incidence and risk factors of atherosclerotic cardiovascular accidents in predialysis chronic renal failure patients: a prospective study. Nephrol Dial Transplant, 1997,12(12):2597

共引文献34

同被引文献7

引证文献1

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部